Opiranserin T16399
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC
CAS nr:
1441000-45-8
Purity:
98%
Molecular Weight:
394,51
SMILES:
CCCCOc1c(OC)cc(cc1OC)C(=O)NCC1(CCOCC1)N(C)C
Formula:
C21H34N2O5
Pathway:
Neuroscience,Neuroscience,Membrane transporter/Ion channel,GPCR/G Protein,Neuroscience
Target:
GlyT,5-HT Receptor,P2X Receptor,5-HT Receptor,P2 Receptor
